Official Title
Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic
Brief Summary

This is a prospective follow-up non-intervention study that will be carried out at Hematology/ Oncology Department, Children's hospital, Ain-Shams University, Cairo, Egypt. All followed-up children below 18 years with cancer during the one year study period from May 2020 till Apr 2021 either at the out-patients clinic or inpatient department will be recruited.

Detailed Description

Study Procedures:

On admission or during the outpatient visit:

1. Obtaining an informed consent .

2. Full medical history, concurrent medications, demographic data and epidemiological data
(history of contact to a COVID-19 case, history of travel), will be obtained.

3. A thorough physical examination will be performed.

4. Body weight, height, BMI, vital signs (blood pressure, heart rate and temperature) and
blood oxygen saturation) will be recorded.

5. Laboratory to perform the following tests:

Complete blood count with differential counts, COVID -19 reverse Transcription Polymerase
Chain Reaction (RT-PCR) test by nasopharyngeal swab.

During admission:

Whenever unexplained fever and or respiratory symptoms developed or whenever COVID19
suspected to have the following to be performed:

1. Symptom developed that necessitates to repeat oropharyngeal and nasopharyngeal swab if
indicated will be collected

2. Chest X-ray or CT chest will be recorded.

3. Laboratory to perform the following tests:

Complete blood count with differential counts,

COVID-19 RT-PCR test by oropharyngeal and nasopharyngeal swab:

C-reactive protein and serum ferritin level. Coagulation test; D. dimer, prothrombin time and
INR. Routine bacteriological study, blood culture and other symptoms/signs based cultures
will be recorded

On discharge:

- Date of discharge

- Period of admission

- Period of fever

- A thorough physical examination will be performed

- Record the outcome

Unknown status
Coronavirus COVID-19
Eligibility Criteria

Inclusion Criteria:

1. Children below 18 years with malignancy either hematological or solid tumors or

2. Children below 18 years with hematological condition

Exclusion Criteria:

1. Patients or care-givers refusal to be enrolled in the study

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: 18 Years
Countries
Egypt
Locations

Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Cairo, Non-US, Egypt

Investigator: Fatma Soliman E Ebeid
Contact: 01095569596
dr.fatma_ebeid@yahoo.com

Contacts

Fatma Ebeid
+201095569596
dr.fatma_ebeid@yahoo.com

Fatma Ebeid, Principal Investigator
Excuitive Director of MARSI-CRC

Fatma Soliman Elsayed Ebeid
NCT Number
MeSH Terms
COVID-19